Pre-Pandemic Timeline
2000 – 2015

Chronological order of significant global, Australian and SA data points leading up to the COVID-19 Pandemic.

Navigate the timeline pages:

1800s | 1900-1945 | 1946-1979 | 1980-1999 | You Are Here | 2016-2018 | 2019 | 2020 | 2021 | 2022 | 2023

Best viewed on a large screen

Data points are continuously being added so please come back again soon

2013
October 2 2013

DARPA awards Moderna $25M for mRNA development

On October 2, 2013 the US Defense Advanced Research Projects Agency (DARPA) through its “synthetic biologyADEPT: PROTECT program, awarded Moderna Therapeutics “up to $25 million to research and develop its messenger RNA therapeutics™ platform as a rapid and reliable way to make antibody-producing drugs to protect against a wide range of known and unknown emerging infectious diseases and engineered biological threats.” Much of this funding will be used over the next 5 years to “advance promising antibody- producing drug candidates into preclinical testing and human clinical trials“. [1] The ADEPT: PROTECT Pandemic Prevention Platform program plans to have the “development and widescale deployment of protective countermeasures” within 60 days from detection of an outbreak. DARPAs’s Autonomous Diagnostics to Enable Prevention and Therapeutics: Prophylactic Options to Environmental and Contagious Threats – ADEPT: PROTECT program seeks to “enable adaptable, diagnostic devices that decrease the time required to design, manufacture, and rapidly distribute test panels in response to evolving or emerging diagnostic needs.”Moderna’s mRNAplatform has the potential to speed the development and manufacture of treatments that can produce a safer, more reliable and more robust immune response than existing technologies.” The ADEPT program began in August 2011 when DARPA began investing in “Controlling Cellular Machinery (CCM) “technologies such as nucleic acid vaccines. The hypothesis was that rather than delivering antigens to the immune system, we could deliver genes that encode the antigen and allow the human body to produce the antigen from its own cells, triggering a protective immune response.” In January 2014 DARPA created a new division called the Biological Technologies Office (BTO), “to explore the increasingly dynamic intersection of biology and the physical sciences” i.e. synthetic biology, neuro-nanotechnology and AI. [2, 3] “DARPA pioneered the use of the body as a bioreactor to produce prophylactic antibodies to protect against biothreats”.  With “[g]ene-encoded antibodies for near-immediate, temporary protection”. [4]  This is different to gene-encoded antigen, which Moderna has claimed in 2020 to be a “vaccine”.
October 23 2013

1st International mRNA Health Conference

On October 23-24, 2013 the 1st International mRNA Health Conference was held in Tübingen, Germany and herald a “New Era in Modern Medicine”,  The event brought together more than 150 attendees from leading international pharmaceutical and biotechnology companies and academic institutions. This conference “laid the foundation for the new biotechnological sector of mRNA-based therapeutics.” [1]

Initiated by CureVac and the University of Tubingen in 2013, and held in the city of Tübingen “where nucleic acids were discovered over 140 years ago”, the confernce became an annual event “for everyone who is working with mRNA for medical purposes or seeking messenger RNA as a novel tool to express proteins directly in situ.” [2]

A whole session was dedicated to mRNA vaccines of which Peter Brossart from the University of Bonn gave a presentation titled “Development of RNA based vaccines” [3]

In Cambridge, Massachusetts on November 11-12, 2014 the second conference was held with gold sponsors being AstraZeneca, BioNTech, CureVac and Moderna. [3]  Moderna Therapeutics’ presenation was titled “Is mRNA like software?“.

In 2014 Lipid Nanoparticle developer Acuitus presented this poster, and DARPA presented the “Impact of mRNA on Global Health

October 30 2013

ACE2 Receptor identified as bat coronavirus infection site for humans.

In an October 30, 2013 paper in Nature, Shi Zheng-Li and Peter Daszak et al reported a key discovery: that certain bat viruses could potentially infect humans without first jumping to an intermediate animal.

By isolating a live SARS-like bat coronavirus (from a rufous horseshoe bat in Yunnan mine 2012) for the first time, bat SL-CoV-WIV1, Shi’s team found that it could enter human cells through a protein called the ACE2 receptor. [1]

2014
January 1 2014

Film excerpt: predicted or coincidence?

In 2014 Former 80’s star from “The Young Ones”, Rik Mayall, released the film called “One by One”, he died suddenly that same year.  This is an alarming 10 minute excerpt.  Is it all fiction?  Was he trying to tell us something?  Is there evidence of this playing out 2020?

January 1 2014

AusVaxSafety is established to actively monitor AEFI

Australia’s Vaccine Safety platform, AusVaxSafety was established in 2014 to actively monitor adverse events following immunisation (AEFI) with influenza vaccines in children, since then it has expanded its scope. The stated purpose is to “optimise community and healthcare provider confidence” in the safety of vaccines, and complement existing programs.

The organisation is led by Australia’s National Centre for Immunisation Research and Surveillance (NCIRS) in collaboration with immunisation providers, private enterprise, research institutions, state and territory governments and the Australian Government Department of Health, and funded by the the government. [3, 4]

Vaccine safety surveillance through AusVaxSafety occurs in 374 selected vaccination clinics around Australia, up from an original 175 sites in 2016-17. Active surveillance is done through survey requests sent out via SmartVax SMS notification on day 3 after vaccination, or “a few days after” the person received a vaccine from a specific location. [1, 2]

Following their first annual report published in 2018, the Department of Health has released 2 more reports: 2019 and 2020 containing infographics of day 3 feedback.   They don’t report on any longer term safety signals.  SmartVax feed reports to the TGA.

Used for COVID-19 AEFI tracking:

  • It appears Vaxtracker, the online survey platform, cuts off surveys at 6 weeks post COVID-19 vaccination.  So the SMS is sent out at 3 days asking for participation in the online survey, which then ends at 6 weeks, and this may just be for select locations.
  • The day 3 COVID-19 vaccine safety monitoring is only charting the already known and expected “commonly reported adverse events”, but doesn’t report on all adverse events that recipients experince, and they don’t report on day 28 or 3 month, for example, follow up which could easily be implemented with their available technology.

In 2020 Professor Allen Cheng an influenza expert, leads all three government vaccine safety advisory groups (Conflicts of Interest?):

  • Chair of the Advisory Committee on Vaccination (ACV) who are regulated to advise the TGA on vaccine products
  • Co-chair of Australian Technical Group on Immunisation (ATAGI) who makes recommendations to the federal and state governments on the use of COVID-19 vaccine following TGA decisions.
  • Expert leader for AusVaxSafety
  • Vice-President of the Australasian Society for Infectious Diseases (ASID)
February 5 2014

PPP: Human Vaccine Project is conceived

Beginning with a May 31, 2013 Science article titled “Accelerating Next-Generation Vaccine Development for Global Disease Prevention” by Plotkins et al, the Robert Wood Johnson Foundation granted $378,000 to the International AIDS Vaccine Initiative (IAVI) on December 16, 2013 to convene international scientists and public-health experts to explore the creation of a Human Vaccines Project that could collectively leverage technological advances to accelerate the development of new vaccines.” [1]

The Human Vaccines Project (HVP) is a global non-profit, public-private partnership (PPP) that brings together leading stakeholders across academia, Big Pharma giants, governments and nonprofits. it was officially conceived in at that confrence on February 5-6, 2014 attended by Stanley Plotkins and 34 other leading vaccine scientists.  They needed to overcome scientific hurdles that impeded the development of revolutionary new vaccines. [2, 3]

Their mission is to “accelerate the development of vaccines and immunotherapiesagainst major global infectious diseases and cancers by decoding the human immune system.” They believe today’s diseases “are much more insidious and biologically complex than those we conquered in the past [4, 5]… and we remain unprepared against the next pandemic.” so “a new approach is needed.” or as they say today “Pioneering a New Era of Human Health”

In July 2014, 20 business leaders from the public and private sectors recommended the Project be structured as a global, nonprofit research and development (R&D) consortium closely engaged with industrial partners, and affiliated with one or more academic centers conducting vaccine R&D…leadership of the Project will then transition from IAVI, its initial catalyst.” [6]

“The Human Vaccines Project has embarked on a decade-long, $1 billion mission to decode the human immune system,” to fight diseses including pandemic flu.  Announced July 1, 2016, applying machine learning should accelerate the plan.  (Alot is ALREADY known).  By October 2, 2022 with the head of IAVI, then HVP, Wayne Koff becomes the CEO & President of the Human Immunome Project, along with Australia’s Nobel Laureate Dr Peter Doherty and MANY more. [7]

  • Feb 13, 2015 – GSK provides grant to establish the Project’s global consortium and plan its research program
  • July 16, 2015 – Vanderbilt Uni Med School joins as first science hub
  • Oct 13, 2015 – AstraZeneca‘s biologics R&D arm MedImmune joins
  • Oct 23, 2015 – Johnson & Johnson (Janssen) joins
  • Jan 14, 2016 – Sanofi Pasteur signs a funding agreement for helping establish the $1B Human Immune Project
  • Feb 10, 2016 – Regeneron joins
  • March 22, 2016 – Pfizer joins to help decode the immune system
  • Jan 4, 2017 – Moderna joins to help help decode the immune system
  • May 8, 2017 – Human Immune Project launched [WEB]
  • Oct. 26, 2017 – HVP launched their Universal Influenza Vaccine Initiative (UIVI) led by Vanderbilt University Medical Center – since “seasonal vaccines are not consistently effective”
  • Jun 28, 2018 – Australia’s Seqirus (CSL Ltd.) partners with project’s UIVI, on 100 year anniversary of 1918 pandemic
  • July 2022 – Universal Coronavirus Vaccine Initiative  for SARS-X, to stop the next pandemic [8, 9]
  • October 2022 – the Human Immunome Project combining systems biology with artificial intelligence, is released

On April 34, 2020 the HVP launched the COVID Vaccine Initiative (CVI) to accelerate COVID-19 vaccine development “for those most vulnerable”. [4]

February 13 2014

Global Health Security Agenda launched

The Global Health Security Agenda (GHSA) was launched in February 13, 2014 in response to “the global threat that infectious diseases constitute in our increasingly interconnected world”. United States joined 28 other countries, the World Health Organization (WHO), the Food and Agriculture Organization (FAO), and the World Organization for Animal Health (OIE), to accelerate progress toward a world safe and secure from the threat of infectious disease, and committing to the goals of the Global Health Security Agenda.

The pledge “means working together to slow the spread of antimicrobial resistance, reducing zoonotic disease transmission, establishing national biosecurity systems, increasing routine immunization, strengthening national infectious disease surveillance and laboratory systems, and developing real-time electronic reporting systems and emergency operations centers.”

By 2022 GHSA is a network of 70 countries, as well as international and non-government organizations, and private sector companies, “working to secure global health security”. [1]

March 23 2014

Ebola oubreak in West Africa – the catalyst for global R&D and regulatory preparedness

On March 23, 2014 the WHO release news of a rapidly evolving outbreak of Ebola virus disease (Ebola Hemorrhagic Fever) in forested areas south eastern Guinea, West Africa. At that date Ministry of Health (MoH) of Guinea were aware of 49 cases with 29 deaths, concluding a case fatality rate of an alarming 59%! The very next day on March 24, 2014 it was communicated “a total of 86 suspected cases in-cluding 59 deaths” providing a case fatality ratio of 69%! [1, 2, 3, 4, 6, 7]

On July 31, 2015 it was reported the “World on the verge of an effective Ebola vaccine”, where Phase III trials of developed of  VSV-EBOV were claimed to be ” highly effective against Ebola”, used in a “ring vaccination protocol”.  The vaccine was developed by the Public Health Agency of Canada, then licensed to NewLink Genetics, and on November 24, 2014 to Merck & Co. [5]  The ring vaccination protocol provided an alternative to using a placebo!

The vaccine trial design group “included Professor Donald A. Henderson of John Hopkins University, who led the WHO smallpox eradication effort by using the ring vaccination strategy”.

In 2003 the WHO stated: “The Ebola virus was first identified in a western equatorial province of Sudan and in a nearby region of Zaire (now Democratic Republic of the Congo) in 1976“.  “Ebola haemorrhagic fever (EHF) is one of the most virulent viral diseases known to humankind, causing death in 50-90% of all clinically ill cases…[it] is transmitted by direct contact with the blood, body fluids and tissues of infected persons”.  Just like smallpox, transmission by direct contact, is indicated to quarantine of the sick to reduce transmission.

Virologist Jean-Jacques Muyembe-Tamfum from the Democratic Republic of the Congo (DRC), at age 34 in 1976, was the first virologist ever to see an Ebola patient, in 2019 vowed to end Congo’s Ebola epidemic. [8, 9]

In August 2019 Dr Anthony Fauci of NIAID, announced the early stopping of an Ebola trial using three antibody preparations and one antiviral drug (remdesivir), carried out in the DRC.  Two treatments “showed strong signs of being able to save patients’ lives”, but remdesivir was withdrawn early, as it proved to increase mortality.


The Ebola outbreak of 2014-15 was as strong catalyst used by the World Health Organisation in 2015 to justify the creation of an R&D Blueprint to accelerate “research and development in epidemics or health emergency situations where there are no, or insufficient, preventive, and curative solutions,” to “spearheaded a global movement to avert full-blown epidemic” or today pandemics! [10, 11]

An important component of accelerated response was ensure National Regulatory Authorities (NRAs) were prepared for public health emergencies (of international concern) – to avoid having to put “emergency regulatory processes in place in the heat of the moment”.

On March 29, 2018 Australia’s legislation, the Therapeutic Goods Act 1989 was amended to include a clause for Provisional Registration – a fast track registration pathway, pushed as an avenue for cancer drugs, and used for brand new, novel drugs like gene transfer technology products classified as “COVID-19 vaccines”.

April 1 2014

Australia’s plan to manage the next pandemic

The Department of Health release the Australian Health Management Plan for Pandemic Influenza (AHMPPI).  (With minor updates in 2019).  With report contributions from Murdoch Children’s Research Institute and Melbourne Uni School of Population Health. [1, 2]

The Minister for Health, The Hon Peter Dutton MP’s opening remarks warn “it is inevitable that the world will face another influenza pandemic.”

Six months later Dutton announced a landmark review of the ways in which the Therapeutic Goods Administration (TGA) regulates medicines, the very review that allows for  the 2018 “Provisional Registration” to be added to the TGA catalogue of registration avenues.

The 2020 pandemic response for COVID-19 follows the pandemic Legal Framework set out in this document, and fast tracked vaccine “approvals” were possible because of Peter Dutton.

June 14 2014

China’s Social Credit System Plan is released

On June 14, 2014 the “Planning Outline for the Construction of a Social Credit System (2014-2020)” was released to the public, as guidelines for the construction of a social credit system.  It sets out the digital dictatorship plan for China. [1]  [A model for the future world?]

“As early as in 2003, the Chinese government expressed interest in creating a comprehensive means of assigning citizens credit scores that would be an improvement over the country’s credit rating system.

The State Council recently approved the “Outline of Regulations for Building a Social Credit System (2014-2020)” and at present eight companies have been granted the central bank’s permission to conduct pilot testing of their own social credit systems, akin to the Fair, Isaac and Company (FICO) consumer credit ratings.

Part of what makes such an endeavor unique in China is the vagueness and in some cases complete absence of regulations regarding big data collection for credit scoring purposes, potential third party uses of such scores, and privacy protections of the user data that factors into credit score calculations. The new cybersecurity law released on November 7, 2016 contains language regarding privacy protections, yet will not be implemented until June 2017.”
Read more>>>

August 27 2014

WHO hold Health and Climate Conference

The World Health Organization (WHO) Conference on Health and Climate took place at the WHO Headquarters in Geneva, Switzerland from August 27-29 , 2014, it was attended by both public and private sector entities. [1]

Throughout the conference, participants discussed linking climate, sustainable development and health policy. A draft summary was produced  “that recognizes both the need to strengthen health resilience to climate change and the opportunity to make gains in public health through well-planned mitigation measures.”

The following month September 23, 2014 the UN held their annual Climate summit.

September 16 2014

Setting the stage for new vaccine technologies

The Foundation for Vaccine Research hosted and organized the first U.S. Senate briefing on progress being made in the development of an Ebola vaccine.  The report called “Vaccines: Entering a bold new era” was led by “the father of vaccines” Professor Stanley Plotkin [1], which sets the stage for the development of new vaccine technologies.

October 7 2014

Grand Challenges re-launched

Established in 2003 the Gates founded the initiative Grand Challenges in Global Health and relaunched it on October 7, 2014 as the  Grand Challenges, where “Bill & Melinda Gates Foundation and Grand Challenge Partners Commit to Innovation with New Investments in Breakthrough Science

The “original US$450 million research initiative was created to catalyze scientific and technological innovation to achieve major breakthroughs in global health.”  This new initiative is to expand to “a family of initiatives fostering innovation to solve key global health and development problems.”

On launch day one initiative was to focus “on accelerating the translation of original and innovative concepts for vaccines, drugs and diagnostics into safe, effective, affordable and widely used interventions for diseases in the developing world.” [5]

Since then the Gates Foundation and other funders, such as the Zuckerberg foundation, continue to launch funding opportunities for new Grand Challenges initiatives, both independently and in partnerships.”[4]

On November 8, 2021, through this initiative the Gates Foundation launched Grand Challenges Global Call-to-Action initiative to “build on lessons from the COVID-19 pandemic and fund cutting-edge science projects that together advance high-priority global health objective.”

Gate’s decides which projects gets the funding and thus plays a key role in directing global health “innovation”, such as “data-centered” health and next generation genomic sequencing! [3]

October 17 2014

US place moratorium on funding Gain-of-Function research

On October 17, 2014, after notification from concerned scientists, over “recent series of laboratory incidents at U.S. facilities” the US Government paused all funding for Gain-of-Function (GoF) studies or research that is “reasonably anticipated to confer attributes to influenza, MERS, or SARS viruses such that the virus would have enhanced pathogenicity and/or transmissibility in mammals via the respiratory route”, simply because chimeric viruses are risky. [2]

The pause was pending adoption of a new policy.  So in October 2014 the National Science Advisory Board for Biosecurity (NSABB) who served as the official federal advisory body on GoF research issues and was responsible for developing recommendations for the appropriate level of Federal oversight of GoF research. Gryphon Scientific was contracted by the NIH Office of Science Policy to conduct risk and benefit assessments of GoF research involving the pathogens subject to the funding pause. They gave their final report in April 2016 following a 2014 and 2016 Gain of Function symposiums. [4]

On December 19, 2017, the National Institutes of Health (NIH), lifts the gain-of-function pause and resumes funding of research that pass their P3CO Framework. [1]

November 1 2014

USAID launch EPT-2 disease threat response program

In November 2014, USAID launched their Emerging Pandemic Threats program 2 (EPT-2).

EPT-2 is focused on mitigating the impact of novel “high consequence pathogens” that originate in animals with a goal of enabling early detection of new disease threats, effectively controlling those threats, enhancing national-level preparedness in advance of outbreaks, and ultimately reducing the risk of these diseases emerging by minimizing human behaviors and practices that trigger the “spill over and spread” of new pathogens. [1]

EPT-2 has three overarching purposes:

  • the prevention of new zoonotic disease emergence,
  • the early detection of new threats when they do emerge,and
  • their timely and effective response

EPT2 consists of a suite of One Health Investments, PREDICT 2, One Health Workforce, and the Preparedness & Response, that contribute to each of these goals and are complemented by strategic investments in key partners including the CDC, U.N. Food and Agriculture Organization, and the World Health Organization.

“PREDICT, a project of USAID’s Emerging Pandemic Threats (EPT) program, was initiated in 2009 to strengthen global capacity for detection and discovery of zoonotic viruses with pandemic potential.  …PREDICT is continuing to build platforms for disease surveillance and for identifying and monitoring pathogens that can be shared between animals and people. Using the One Health approach, the project is investigating the behaviors, practices, and ecological and biological factors driving disease emergence, transmission, and spread. Through these efforts, PREDICT will improve global disease recognition and begin to develop strategies and policy recommendations to minimize pandemic risk.”

:PREDICT 2 is continuing efforts to shift the prevention and surveillance paradigm towards identification and mitigation of viral spillover and amplification risk.”

Implementing partners for PREDICT-2 are University of California-Davis, EcoHealth Alliance, Metabiota, Smithsonian Institution, and Wildlife Conservation Society.

November 6 2014

The UN “Data Revolution” begins

On August 29, 2014 UN Secretary-General Ban Ki-moon announced the establishment of an Independent Expert Advisory Group (IEAG) on the Data Revolution for Sustainable Development with two co-chairs: Professor Enrico Giovannini of Italy and Mr. Robin Li of China. [1, 2]

The group was “to make concrete recommendations on bringing about a data revolution in sustainable development.” “To propose ways to improve data for achieving and monitoring sustainable development”. The on November 6, 2014 the IEAG released their report titled “‘A World that Counts: Mobilising theData Revolution for Sustainable Development.’ [2, 3, 4, 5]  The report reveals mobile phone use shaply increased from 2010.

The need for a ‘data revolution’ was first expressed in a May 30, 2013 report by the High Level Panel, appointed by UN Secretary-General Ban Ki-moon in July 2012 to make recommenations on the “Post-2015 Development Agenda”. [2]

2015
January 1 2015

Australian Communicable Diseases Genomics Network is established

In 2015 the Communicable Diseases Genomics Network (CDGN) was established with an overarching aim of implementing genomics into clinical and public health microbiology in a network of public health laboratories across Australia.

In 2019, the network was formalised as an Expert Reference Panel under the Australian Government Public Health Laboratory Network (PHLN), a standing committee under the Australian Health Protection Principal Committee (AHPPC).

CDGN is affiliated with The Doherty Institute who provide government with modelling scenarios, and funding is provided by Department of Health.

Led by The Doherty Institute in 2020, COVID-19 gave rise to fast tracking their framework and their national genomics surveillance platform, AusTrakka. [1, 2]

From June 8, 2020, the PHLN set guidance on PCR tests.

February 1 2015

Bank of England is first to raise CBDC concept

In February 2015 the Bank of England released their reportOne Bank Resarch Agenda” first raised the concept of a central bank digital currency (CBDC). [1]

Then in March 2017 the MIT Media Lab then launched the MIT Digital Currency Initiative, looking at helping create “digital fiat currency“. [2, 3]

On January 8, 2009 a white paper titled “Bitcoin: A Peer-to-Peer Electronic Cash System” was released by the pseudonym Satoshi Nakamoto. Four months later, the first open-source Bitcoin client software was made available to the public. [4, 5] Australia’s Craig Wright claims to be the author of that paper.

March 18 2015

TED Talk – Bill Gates: The next outbreak? We’re not ready

In March 18, 2015 at a TED Talk in Vancouver, in his presentation Bill Gates warned the world that we’re not ready for the next pandemic.  A highly infectious virus is likely to kill 10 million people in the next decade rather than a war! [4] –  WATCH

In April 2020 the BBC commented to Bill that his 2015 TED Talk was “extraordinarily close to what is happening now”!

On the same speaker list with Bill was his GAVI CEO Seth Berkley who shared that “It seems like we wait for a disastrous disease outbreak before we get serious about making a vaccine for it.” [3]  Also on the speakers list were Paul Tudor Jones II on Rethinking Capitalism [6], Dan Ariely on Society’s Growing Inequality [5].

Interestingly in the same TED2015 “Truth and Dare” program Marina Abromovic gave a presentation.   The same “artist” who Microsoft used in their April 2020 headset advertisement before they removed it. [1, 2]

March 26 2015

Peter Daszak’s prophetic statement to NAS workshop

On March 26 and 27, 2015, the Institute of Medicine convened a workshop at the National Academy of Sciences (NAS) in Washington, DC titled “Enabling Rapid Response and Sustained Capability with Medical Countermeasures (MCM) to Mitigate Risk of Emerging Infectious Diseases.”  The workshop summary report was published February 12, 2016 by the National Academies Press.

At the workshop Peter Daszak, president of EcoHealth Alliance, spoke for the topic “Enabling Sustainable Capabilities Through Ongoing Public- and Private-Sector Partnerships”, where he made the following prophetic remark in relation to Developing Medical Countermeasures (MCM) for Coronaviruses:

…until an infectious disease crisis is very real, present, and at an emergency threshold, it is often largely ignored. To sustain the funding base beyond the crisis… we need to increase public understanding of the need for MCMs such as a pan-influenza or pan-coronavirus vaccine. A key driver is the media, and the economics follow the hype. We need to use that hype to our advantage to get to the real issues. Investors will respond if they see profit at the end of process…”

Read that again. [1] Then WATCH this.

Dr Martin:  Peter Daszak in 2015 actually stated that “this entire exercise was a campaign of domestic TERROR to get the public to accept the universal vaccine platform using a know biological weapon.”


Fast forward November 7 2021, Bill Gates’ post 2015 pandemic preparedness “prophecies” weren’t heeded with Ebola, but COVID-19 pandemic allowed for R&D budgets to focus on things we didn’t have.

He recounts what wasn’t achieved in this pandemic:

we didn’t have vaccines that blocked transmission…we need a new way of doing the vaccines”…”we didn’t get much by way of therapeutics”…”we didn’t get the diagnostics up and running in order to achieve, well at least Australia and New Zealand [both island continents] showed that competent management could keep the death rate down pretty dramatically”.  It will take tens of billions in R&D

April 23 2015

Chatham House project begins for Strengthening Data Sharing for Public Health

Chatham House Centre on Global Health Security held high-level Strategy Roundtable on April 23, 2015 for The Strengthening Data Sharing for Public Health project.  The aim of the secret meeting (Chatham House Rules) “was to stimulate a high-quality dialogue among experts from a broad range of data sharing environments to help inform the project and its strategy going forward.” [1, 2]

At this time there is “no global framework or operational guidance for systematic sharing of public health surveillance data.”

Stated in the report “There is potential to build from the International Health Regulations and from the Pandemic Influenza Preparedness (PIP) Framework (which promotes virus sequence sharing and benefit sharing) to develop a new framework of evolving guidelines and principles specifically around public health data sharing – which could be endorsed by the WHO and other international bodies”

Financial support was provided by the Bill & Melinda Gates Foundation.

In May 2017 Chatham House released “A guide to sharing the data and benefits of public health surveillance” which the WHO promote as part of their R&D Blueprint [3], and works with other non-state actors.

June 10 2015

Paper: Only 2 coronavirus spike mutations necessary for bat-to-human transmission

A paper published online June 10, 2015, and co-authored by Dr Ralph Baric (University of North Carolina Chapel Hill) and Zhengli Shi (Wuhan Institute of Virology) reveals that only two mutations are necessary in the spike protein region of a non-infectious bat coronavirus (HKU4) to make it infectious to humans via ACE2 receptor.  Thus coronaviruses could jump directly from bats to humans! [1]

In 2002 Ralph Baric et al patented the method for making coronaviruses infectious to humans via the ACE2 receptor.

June 16 2015

Donald J. Trump announces run for President

On June 16, 2015, business man and entrepreneur, Donald John Trump announced, in the basement of Trump Tower, that he would run for the office of the President of the United States of America.

June 16 2015

Australia: Biosecurity Act (2015) passed

The Australian Biosecurity Act (2015) was passed by parliament June 16, 2015, which superseded the Quarantine Act 1908.  Built in to this act are human rights safeguards.

Fast forward: A Biosecurity Emergency was declared on March 19, 2020, but only 2 Australian borders directions were declared under the Act.  All other “pandemic response” measures were passed off to each state and territory of Australia.

It is important to understand that only when a Federal law is in conflict with the State does the Federal law override it.  Each Australia state and territory enacted their own emergency powers in March 2020, which were not in conflict with external border directions – as such, state powers have bypassed human rights and constitutional laws

September 25 2015

UN 2030 Agenda for Sustainable Development signed

Following 3 years of negotiations, on September 25, 2015, the United Nations General Assembly formally adopted the 2030 Agenda for Sustainable Development, along with a set of 17 Sustainable Development Goals (SDG) and 169 associated targets. This builds on and broadens the utopian targets of the 2000-2015 UN Millennium Development Goals (MDG).

If the world is to eradicate poverty, address climate change and build peaceful, inclusive societies for all by 2030, key stakeholders, including governments, must drive implementation of the Sustainable Development Goals (SDGs)…”[1]  (And so the “ZERO” targets begin, with the ultimate goal of zero poverty)

The UN Resolution UN A/Res/70/L1 ‘Transforming our World: the Agenda 2030 for Sustainable Development “outlined an ambitious vision for a new era of global development from 2016 – 2030“..”for achieving a fairer, safer and healthier world”. [2, 3, 4]

UN’s 1992 Agenda 21 was significantly expanded to become Agenda 2030, a 15 year plan to achieve 17 Sustainable Development Goals (SDGs) to create utopia by 2030 and “leave no one behind”, signed by 193 member states including Australia.

Health utopia will be achieved through vaccinating everyone, through the new decade of vaccines agenda IA2030, in addition to Bill Gate’s Decade of Vaccines (2010-2020).

Following the signing of this 2030 Agenda the COP21 delagated met on December 12, 2015 the legally binding global climate deal – the Paris Agreement on climate change was signed by 195 member states.

October 5 2015

Nobel Prize awarded for Ivermectin

William C. Campbell and Satoshi Ōmura who discovered the soil derived drug, Avermectin, which was subsequently chemically modified to a more effective compound called Ivermectin were awarded the Nobel Prize in Physiology or Medicine on October 5, 2015.

Ivermectin became a controversial drug during 2020 as it was shown by Dr Kory, Dr Marik and Dr Lawrie to be highly effective in treating COVID-19, but that information threatened the global “public health” vaccination policy and eligibility for Emergency Use around the world.

November 9 2015

Study concludes engineered viruses may be too risky to pursue

Chinese virologist Shi Zheng-Li in Wuhan, together with US virologist Ralph Baric, published a paper that “synthetically re-derived an infectious…virus”, concluding that building chimeric viruses maybe too risky to pursue.

They took a 2002 SARS virus and inserted the protein from a rufous horseshoe bat, creating a new infectious human pathogen.  It was intended to “warn the world” of a potential risk of SARS-CoV re-emergence!

The study was funded by NIH via EcoHealth Alliance, and NGO who’s president is Peter Daszak.  This study was approved by NIH to continue even though it came under the Gain of Function funding moratorium.

In 2020, Daszak thanked Dr Fauci via email, for dismissing theories that SARS-CoV-2 could be man-made.

In February 2021, Daszak represented the US on the WHO probe in to the origins of SARS-CoV-2.

November 10 2015

“Little is known” about using LNPs to deliver mRNA

A paper published on November 10, 2015 by future nobel prize nominees Drew Weissman and Katalin Kariko et al, they stated that “little is known” about the potential of using Lipid Nanoparticles (LNPs) to deliver mRNA.

They proceeded to demonstrate that a pseudouridine-modified mRNA that codes for the luminescent enzyme, luciferase, when encapsulated in LNPs and delivered via various routes into mice, it does enter cells and successfully translate the mRNA code into the luciferase protein. They showed it can last up to 10 days and moves into the liver, where there it translates for 1-4 days.

Natural (non-modified) mRNAs breakdown fast.  The use of the LNPs protects this modified mRNA en-route to the cells and allows the entry of the mRNA into the cells where the code can be translated by the cells machinery.  But do you want every cell making the protein, and what are the consequences of the mRNA hanging around for up to 10 days (in this study)? [1]

December 12 2015

UN Paris Agreement on Climate Change is signed

Following the signing of UN 2030 Agenda the Paris Climate Change Conference (COP21) was held from Nov 25 to Dec 12, 2015 in Paris.  On December 12, 2015 of the meetings the first-ever universal, legally binding global climate deal – the Paris Agreement on climate change was signed by 195 member states. [1]

The Paris Agreement “sets out a global action plan to put the world on track to avoid dangerous climate change by limiting global warming to well below 2°C.” [2, 3, 4]  All countries agreed to reduce their carbon emission by 2030, except China and India who were allowed to double theirs – a bogus deal.

The new “sustainable” or “green” economic paradigm highly correlates with the 1934 Technocracy resource-based economic system that uses energy as the “currency”, think “carbon credits” emissions trading.  But who would be the “bank“? [5, 6]

Timeline pages:

1800s | 1900-1945 | 1946-1979 | 1980-1999 | 2000-2015 | 2016-2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024

Scroll to Top